Immusant

Develops therapeutics and diagnostics for the diagnosis and treatment of celiac disease

placeCambridge, Massachusetts, United States calendar_todayFounded 2010 groups2 employees language immusant.com

Registered entities

Investor mix

3 investors on record; lead investors include Arch Venture Partners, Vatera Healthcare Partners, T1D Fund.

Investor typeCountShare
Venture capital267%
Private equity133%
Coming soon